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molecular  determinants  of  ion  channel  tetramerization  are  well  characterized,  but  those   
involved  in  heteromeric  channel  assembly  are  less  clearly  understood.  The  heteromeric 
composition of native channels is often precisely controlled. Cyclic nucleotide-gated (CnG) 
channels from rod photoreceptors exhibit a 3:1 stoichiometry of CnGA1 and CnGB1 subunits 
that tunes the channels for their specialized role in phototransduction. Here we show, using 
electrophysiology, fluorescence, biochemistry, and X-ray crystallography, that the mechanism 
for this controlled assembly is the formation of a parallel 3-helix coiled-coil domain of the 
carboxy-terminal leucine zipper region of CnGA1 subunits, constraining the channel to contain 
three  CnGA1  subunits,  followed  by  preferential  incorporation  of  a  single  CnGB1  subunit. 
Deletion of the carboxy-terminal leucine zipper domain relaxed the constraint and permitted 
multiple CnGB1 subunits in the channel. The X-ray crystal structures of the parallel 3-helix 
coiled-coil domains of CnGA1 and CnGA3 subunits were similar, suggesting that a similar 
mechanism controls the stoichiometry of cone CnG channels. 
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T
he precise assembly of many ion channels relies on a mul-
timerization domain that assembles compatible subunits and 
excludes incompatible subunits. In the voltage-gated family 
of channels, these multimerization domains take the form of either 
an  amino-terminal  tetramerization  domain  (T1  domain)1,2  or  a 
carboxy-terminal four helix coiled-coil domain3–5. Although chan-
nel assembly is generally permitted without these multimerization 
domains,  such  domains  confer  subunit-specific  assembly,  often 
restricting the channel composition to like-subunits.
Cyclic nucleotide-gated (CNG) channels, however, have a more 
complex subunit composition. Native CNG channels are composed 
of a stereotyped number of CNGA subunits and CNGB subunits. 
CNGA and CNGB subunits are structurally related and both are 
thought to contribute to the formation of the pore. The CNG chan-
nel from rod photoreceptors is composed of three CNGA1 subunits 
and one CNGB1 subunit6–8, whereas the CNG channel from olfac-
tory receptors is composed of two CNGA2 subunits, one CNGA4 
subunit and one CNGB1b subunit9. The cone CNG channels com-
prise  CNGA3  subunits  and  CNGB3  subunits,  though  the  subu-
nit stoichiometry is still unknown8,10. The presence of the CNGB 
subunits confers enhanced Ca2 +  permeation, modulation by Ca2 + -
calmodulin, and native-like cyclic-nucleotide specificity compared 
with  homomeric  CNGA  channels11–17.  The  precisely  controlled 
subunit compositions, therefore, tune the CNG channels for their 
specialized roles in phototransduction and olfactory transduction.
CNG channels are activated by the direct binding of intracellular 
cyclic  nucleotides18.  They  are  members  of  the  voltage-gated  ion 
channel superfamily, consisting of four subunits around a centrally 
located  pore.  The  intracellular  carboxy-terminal  region  of  each 
subunit  consists  of  a  C-linker  region,  a  cyclic  nucleotide-bind-
ing domain (CNBD), and a post-CNBD region (Fig. 1a). The X-
ray crystal structure of the carboxy-terminal region of the related 
hyperpolarization-activated cyclic nucleotide-gated channel reveals 
a four fold symmetric tetramer with non-interacting CNBDs and 
extensive intersubunit interactions between C-linker regions19.
How does the complex subunit composition of CNG channels 
come about? The CNGA subunits contain a carboxy-terminal leucine   
zipper  (CLZ)  domain  in  the  post-CNBD  region  (Fig.  1a,b)8.   
On the basis of the finding that the CLZ domain from CNGA3 
forms homotypic trimers in solution, it was proposed that trimeri-
zation  of  this  domain  constrains  the  channel  to  contain  three   
CNGA subunits8. Previously, it has been shown that point muta-
tions  in  this  domain  decreased  the  proportion  of  heteromeric   
channels (relative to CNGA homomers) but did not alter the 3:1 
stoichiometry of the heteromeric channels20.
Here  we  test  the  role  of  the  CLZ  domain  by  measuring  the   
subunit  composition  of  CNGA1 + CNGB1  channels  when  the   
CLZ domain in the CNGA1 subunit was deleted. Using electro-
physiology and fluorescence measurements, we found that deletion 
of the CLZ domain relaxed the constrained subunit stoichiometry. 
This allowed more than one CNGB1 subunit in the channel and 
conferred novel pharmacological properties and cyclic nucleotide 
specificity.  Using  X-ray  crystallography,  we  found  that  the  CLZ 
domains of both CNGA1 and CNGA3 formed homotypic parallel 
3-helix coiled-coil domains, consistent with their proposed role in 
regulating subunit assembly.
Results
Deletion of the CLZ domain affects cyclic nucleotide specificity. 
To determine the role of the CLZ domain in controlling heteromeric 
assembly  of  CNGA1 + CNGB1  channels,  we  first  measured  the 
functional effects of deleting the CLZ domain. CNG channels were 
expressed  in  Xenopus  oocytes  and  studied  using  the  inside–out 
configuration of the patch-clamp technique. Homomeric channels 
of CNGA1 subunits are efficiently activated by saturating cGMP, 
but poorly activated by saturating cAMP (IcAMP/IcGMP = 0.05 ± 0.01, 
n = 6)  (Fig.  2a,  black  is  with  2.5 mM  cGMP,  red  is  with  16 mM 
cAMP). However, incorporation of a single CNGB1 subunit per 
tetramer confers a significant elevation in cAMP efficacy (IcAMP/
IcGMP = 0.22 ± 0.03, n = 7) (Fig. 2a). The mechanism of the increased 
cAMP efficacy by the CNGB1 subunit is unknown but could involve 
either  cAMP  binding  to  CNGB1  or  simply  a  more  favourable 
opening transition with CNGB1 (or both). This increased efficacy is 
constant over a wide range of CNGB1 expression levels, indicating 
that the CNGB1 subunit incorporates into the channel with a fixed 
and tightly-regulated stoichiometry15.
Previously, it has been shown that the amino-terminal region of 
the CNGB1 subunit interacts with the CLZ domain of the CNGA1 
subunit  and  regulates  trafficking  of  heteromeric  channels21.  To 
test for a possible role of this interaction in subunit assembly, we 
deleted the amino-terminal region (amino acids 2-765) of CNGB1 
(CNGB1-∆N). Co-expressing CNGA1 and CNGB1-∆N produced 
robust currents with amplitude similar to that of CNGA1 + CNGB1 
(ref. 21). In addition, as shown in Figure 2a, deletion of the amino-
terminal region of CNGB1 had no effect on the cAMP efficacy of the 
heteromeric channels (IcAMP/IcGMP = 0.21 ± 0.03, n = 7). These results 
suggest that the amino-terminal domain of CNGB1 is not required 
for the proper assembly of functional heteromeric channels.
Next, we tested the effects of deletion of the CLZ domain (amino 
acids  609–693)  of  the  CNGA1  subunit  (CNGA1-∆CLZ).  Dele-
tion of the CLZ domain had no effect on the expression or meas-
ured functional properties of CNGA1-∆CLZ homomeric channels   
(Fig. 2a)21. However, it had a dramatic effect on expression and func-
tional properties of CNGA1-∆CLZ +  CNGB1 heteromeric channels. 
As shown previously, co-expression of CNGA1-∆CLZ with CNGB1 
at a typical 1:4 RNA ratio virtually eliminated all functional chan-
nel expression (Fig. 2a)21. This dominant negative effect may under-
lie one form of retinitis pigmentosa resulting from deletion of a   
portion of the CLZ domain in CNGA1 (refs 21,22) and suggests 
that the CNGA1-∆CLZ channels are still interacting with CNGB1, 
perhaps in an uncontrolled manner.
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Figure 1 | Heteromeric rod CNG channel. (a) Cartoon of the heteromeric 
rod CnG channel composed of three CnGA1 subunits (red) and one 
CnGB1 subunit (green). The intracellular carboxy-terminal domain 
contains a C-linker, CnBD, and CLZ domain (only on the CnGA subunits). 
(b) sequence alignment of CLZ domains of the different CnGA subunits 
from bovine (b), rat (r) and human (h). Residues predicted to lie in the  
‘a’ and ‘d’ positions of heptad repeats are shown in magenta.ARTICLE     
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To recover functional expression of heteromeric channels, we 
co-injected  CNGA1-∆CLZ  with  CNGB1-∆N  containing  a  dele-
tion  of  the  trafficking  signal  in  the  amino-terminal  region  of 
CNGB1  (ref.  21).  Even  at  an  RNA  ratio  of  1:2  CNGA1-∆CLZ:
CNGB1-∆N, the effect of the CLZ domain deletion on the hetero-
meric channels was striking. Co-expression of CNGA1-∆CLZ and 
CNGB1-∆N yielded channels with a highly elevated cAMP efficacy 
(IcAMP/IcGMP = 0.38 ± 0.02, n = 10) (Fig. 2a), significantly higher than 
CNGA1 homomeric channels and CNGA1 + CNGB1 heteromeric 
channels (Fig. 2b). The elevated cAMP efficacy seen with the CLZ 
domain deletion in heteromeric channels, but not homomeric chan-
nels, suggests the possibility that CNGA1-∆CLZ and CNGB1-∆N 
form  heteromeric  channels  with  a  novel  stoichiometry,  perhaps 
with more than one CNGB1 subunit per channel.
Effects of deletion of the CLZ domain on L-cis-diltiazem block. 
To  further  test  for  incorporation  of  multiple  CNGB1  subunits 
on deletion of the CLZ domain, we measured the pharmacologi-
cal  properties  of  heteromeric  channels.  Although  100 µM  L-cis-
diltiazem is ineffective at blocking CNGA1 homomers, it potently 
blocks  CNGA1 + CNGB1  heteromers  (Fig.  3a,  black  is  control, 
blue  is  100 µM  L-cis-diltiazem)17.  The  block  is  voltage  depend-
ent with a Hill slope of one, suggesting a pore-blocking mecha-
nism (Fig. 3a,b). The CNGA1-∆CLZ mutation had no effect on 
block  of  homomeric  channels,  and  the  CNGB1-∆N  mutation 
had no effect on block of heteromeric channels. Surprisingly, the 
block  of  CNGA1-∆CLZ + CNGB1-∆N  heteromers  was  inter-
mediate  between  CNGA1  (or  CNGA1-∆CLZ)  homomers  and 
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Figure 2 | Deletion of the CNGA1 CLZ domain increased the cAMP 
efficacy of heteromeric CNG channels. (a) Leak subtracted macroscopic 
current traces from inside–out patches in the presence of 2.5 mm 
cGmP (black) and 16 mm cAmP (red) in response to voltage pulses 
of  − 60 mV and  + 60 mV. Currents were recorded for CnGA1 only (top 
left), CnGA1-∆CLZ only (bottom left), CnGA1 + CnGB1 (top middle), 
CnGA1-∆CLZ  + CnGB1 (bottom middle), CnGA1 + CnGB1-∆n (top right), 
CnGA1-∆CLZ  + CnGB1-∆n (bottom right). (b) IcAmP/IcGmP at  + 60 mV 
for each channel composition: CnGA1 (n = 6), CnGA1-∆CLZ (n = 6), 
CnGA1 + CnGB1 (n = 7), CnGA1-∆CLZ  + CnGB1 (n = 7), and CnGA1-
∆CLZ  + CnGB1-∆n (n = 10). The expected subunit stoichiometry for each 
case is shown at the bottom. Data are plotted as mean ± s.e.m. Asterisks 
denote statistically significant differences with P < 0.01.
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Figure 3 | Deletion of the CNGA1 CLZ domain confers intermediate  
L-cis-diltiazem block on heteromeric CNG channels. (a) cGmP-activated 
current traces from inside–out patches in the absence (black) and 
presence (blue) of 100 µm L-cis-diltiazem in response to voltage pulses 
of  − 60 mV and  + 60 mV. Currents were recorded for CnGA1 only (top 
left), CnGA1-∆CLZ only (bottom left), CnGA1 + CnGB1 (top middle), 
CnGA1-∆CLZ  + CnGB1 (bottom middle), CnGA1 + CnGB1-∆n (top 
right), and CnGA1-∆CLZ  + CnGB1-∆n (bottom right). (b) Dose-response 
relations of L-cis-diltiazem block at  + 60 mV for CnGA1 only (n = 5, filled 
squares), CnGA1-∆CLZ only (n = 6, open squares), CnGA1 + CnGB1 (n = 5, 
filled circles), CnGA1 + CnGB1-∆n (n = 5, open circles), and CnGA1-
∆CLZ  + CnGB1-∆n (n = 4, filled triangles). Data are plotted as mean ±  
s.e.m. Data are fitted with a single Langmuir isotherm or the sum of two 
Langmuir isotherms (for CnGA1-∆CLZ  + CnGB1-∆n). The dashed line 
shows the poor fit of CnGA1-∆CLZ  + CnGB1-∆n with two Langmuir 
isotherms with affinities constrained to those of CnGA1-∆CLZ only and 
CnGA1 + CnGB1-∆n. (c) Dose-response relation of L-cis-diltiazem block 
at  + 60 mV for CnGA1-∆CLZ  + CnGB1-∆n at an RnA ratio of 1:1 (orange 
triangles) fitted with the sum of two Langmuir isotherms (orange line). 
single Langmuir isotherms from CnGA1 only and CnGA1 + CnGB1 are 
shown in grey and the sum of two Langmuir isotherms from CnGA1-
∆CLZ  + CnGB1-∆n at an RnA ratio of 1:2 is shown in black. (d) Cartoon 
depicting how interactions between a single molecule of L-cis-diltiazem 
(blue), and CnGA1 (red) and CnGB1 (green) subunits, could produce an 
intermediate affinity for channels containing multiple CnGB1 subunits.ARTICLE
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CNGA1 + CNGB1 (or CNGA1 +  CNGB1-∆N) heteromers (Fig. 3a).   
Previously,  it  was  shown  that  heteromers  formed  with  point   
mutations in the CLZ domain of CNGA3 exhibited intermediate 
block by L-cis-diltiazem because they formed mixtures of CNGA3 
homomers  and  CNGA3 + CNGB1  heteromers20.  However,  that 
was not the case here. As shown above, CNGA1-∆CLZ + CNGB1-
∆N heteromers actually exhibit greater cAMP efficacy than either 
CNGA1  homomers  or  CNGA1 + CNGB1  heteromers  (Fig.  2). 
Together, these results indicate the formation of a previously unchar-
acterized population of heteromeric CNG channel complexes.
To unravel the cause of this intermediate block, we measured 
the dose-response relations for L-cis-diltiazem block at  + 60 mV. 
The dose-response relations for channels containing CLZ domains 
were well fit with a single Langmuir isotherm, suggesting a single 
population of channels (Fig. 3b). The block of CNGA1 and CNGA1-
∆CLZ homomers were similar and low affinity (K1/2 = 174 ± 7.2 µM, 
n = 5 and K1/2 = 164 ± 8.2 µM, n = 6, respectively), and the block of 
CNGA1 + CNGB1  and  CNGA1 +   CNGB1-∆N  heteromers  were 
similar  and  high  affinity  (K1/2 = 2.45 ± 0.28 µM,  n = 5  and  K1/2 =   
1.40 ± 0.21 µM,  n = 5,  respectively)  (Fig.  3b).  The  dose-response 
relation  for  block  of  CNGA1-∆CLZ + CNGB1-∆N  heteromers, 
however, was not fit well by either a single Langmuir isotherm, nor 
by the sum of two Langmuir isotherms with affinities constrained 
to those of CNGA1 homomers and CNGA1 + CNGB1 heteromers. 
Instead, fits to the sum of two Langmuir isotherms revealed a small 
high affinity component similar to that of CNGA1 + CNGB1 chan-
nels  (K1/2 = 0.56 ± 0.09 µM,  n = 4),  and  a  larger  component  with 
an affinity intermediate between that of CNGA1 homomers and 
CNGA1 + CNGB1  heteromers  (K1/2 = 50 ± 5 µM,  n = 4)  (Fig.  3b). 
These results suggest that the heteromers formed from CNGA1-
∆CLZ and CNGB1-∆N are not a mixture of CNGA1 homomers   
and normal CNGA1 + CNGB1 heteromers, but, instead, a mixture   
of normal 3:1 CNGA1 + CNGB1 heteromers and novel CNGA1 +   
CNGB1 heteromers.
One intriguing possibility is that the novel heteromers formed 
without  a  CLZ  domain  contain  multiple  CNGB1  subunits.  This 
would also suggest that whereas one CNGB1 subunit confers much 
greater  L-cis-diltiazem  affinity,  extra  CNGB1  subunits  lower  the   
L-cis-diltiazem affinity (Fig. 3d). This model predicts that lowering 
the relative amount of expressed CNGB1 subunits should actually 
increase the fraction of the high affinity component (due presum-
ably  to  channels  with  the  normal  3:1  CNGA1:CNGB1  stoichio-
metry), because a lower amount of CNGB1 should favour a subunit 
stoichiometry with fewer CNGB1 subunits. The results of such an 
experiment are shown in Figure 3c. Lowering the RNA co-injec-
tion ratio of CNGA1-∆CLZ and CNGB1-∆N from 1:2 to 1:1 signifi-
cantly increased the fraction of the high affinity component from 
0.21 ± 0.01, n = 3 to 0.40 ± 0.01, n = 4. In addition, the dose-response 
relation is now poorly fit by a sum of two Langmuir isotherms and is 
suggestive of a third component with an affinity similar to CNGA1 
homomers. Together, these results suggest that deletion of the CLZ 
domain removes the constraint allowing only one CNGB1 subunit 
in  the  channel  tetramer.  This  allows  multiple  CNGB1  subunits   
that  confer  higher  efficacy  for  cAMP  and  (surprisingly)  lower   
affinity  for  L-cis-diltiazem  block  (Fig.  3d).  If  channels  contain-
ing three CNGB1 subunits were not functional or not trafficked   
properly  to  the  plasma  membrane,  then  this  loss  of  controlled   
assembly  could  also  explain  the  large  dominant  negative  effect 
of CNGB1 subunits, when the CLZ domain is deleted from the 
CNGA1 subunit.
Fluorescence  measurements  of  multiple  CNGB1  subunits.   
To directly measure the presence of multiple CNGB1 subunits in the 
channel, we turned to an approach based on fluorescence resonance 
energy transfer (FRET)23. FRET reports the proximity of two fluoro-
phores based on the efficiency of energy transfer between a donor 
fluorophore and an acceptor fluorophore. FRET can be detected by 
an enhanced emission of the acceptor fluorescence on excitation of 
the donor. Cyan fluorescent protein (eCFP) and yellow fluorescent 
protein (eYFP) are genetically-encoded donor and acceptor fluoro-
phores, respectively, that can be fused to proteins of interest24. They 
exhibit 50% energy transfer at a distance of about 50 Å and meas-
urable transfer up to 80 Å (ref. 25), making them ideally suited for 
measurements of subunit composition7. Previously it was shown 
that if CNGA1 subunits are fused to eCFP and eYFP (individu-
ally) and co-expressed with CNGB1 subunits in Xenopus oocytes, 
there was significant FRET for channels in the plasma membrane7. 
However, if CNGB1 subunits were fused to eCFP and eYFP and   
co-expressed with CNGA1 subunits, there was little or no FRET 
(Fig. 4a). These results revealed that heteromeric rod CNG channels   
in the plasma membrane contain multiple CNGA1 subunits but 
only a single CNGB1 subunit (3:1 stoichiometry).
We  performed  a  similar  experiment  to  determine  if  deletion   
of the CLZ domain permitted incorporation of multiple CNGB1 
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Figure 4 | FRET experiments reveal multiple CNGB1 subunits when the 
CNGA1 CLZ domain is deleted. (a) Predictions for FRET between eCFP-
CnGB1-∆n and eYFP-CnGB1-∆n for channels containing just a single 
CnGB1 subunit (left) or possibly multiple subunits (right). Possibilities 
for FRET are shown by arrows. (b) Emission spectra of Xenopus oocytes 
expressing CnGA1-∆CLZ with both eCFP-CnGB1-∆n and eYFP-CnGB1-
∆n with 458 nm excitation (red) or 488 nm excitation (black). A scaled 
eCFP only excitation is shown in blue and extracted spectrum (difference 
between red and blue) is shown in yellow. Ratio A is the ratio of the yellow 
to the black spectrum. (c) Emission spectra of CnGA1-∆CLZ + eYFP-
CnGB1-∆n coloured as in (b). Ratio Ao is the ratio of the red to the black 
spectrum. (d) Ratio A-Ratio Ao for FRET between CnGB1 subunits with 
(n = 8) and without (n = 6) the CLZ domain in the CnGA1 subunit. (e) Ratio 
A-Ratio Ao for FRET between CnGA1 and CnGB1 subunits with (n = 6) and 
without (n = 4) the CLZ domain in the CnGA1 subunit. Data are plotted as 
mean ± s.e.m. Asterisks indicate statistically-significant differences, with 
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subunits  into  the  heteromeric  channels.  If  there  are  multiple   
CNGB1  subunits  in  the  heteromeric  channels,  then  we  should 
observe FRET between CNGB1 subunits when fused to eCFP and 
eYFP  and  co-expressed  with  CNGA1-∆CLZ  subunits  (Fig.  4a). 
For these experiments, we fused eCFP and eYFP (individually) to 
the amino-terminal end of CNGB1-∆N (eCFP- CNGB1-∆N and 
eYFP- CNGB1-∆N respectively). The eCFP and eYFP fusion con-
structs exhibited functional properties indistinguishable from their 
non-fusion counterparts (data not shown). As the amino-terminal 
region is deleted in this subunit, the fluorescent proteins should be 
near the inner leaflet of the membrane, close to the S1 transmem-
brane segment. Based on the structure of the related Kv1.2 chan-
nel26, two fluorescent proteins in the same channel should be about 
56 Å apart (assuming they are in adjacent subunits) or 79 Å apart 
(assuming they are in nonadjacent subunits).
Representative results from co-expression of CNGA1-∆CLZ with 
eCFP- CNGB1-∆N and eYFP- CNGB1-∆N are shown in Figure 4b.   
FRET was measured from the sensitized emission of the acceptor 
using fluorescence spectra23. The fluorescence emission spectra from 
channels in or near the plasma membrane of live Xenopus oocytes 
were measured with confocal microscopy. Excitation of eCFP with 
a 458 nm laser produced a complex emission spectrum (red trace) 
with both eCFP and eYFP emission components. The eYFP com-
ponent  (orange  trace)  was  extracted  by  subtracting  off  a  scaled 
emission spectrum from eCFP alone (blue trace). This extracted 
spectrum contains eYFP emission from both FRET and direct exci-
tation of eYFP by 458 nm light. To isolate the component due to 
FRET, the fractional excitation of eYFP by 458 nm light relative to 
488 nm light (Ratio Ao) (Fig. 4c, Methods) was subtracted off the 
corresponding fractional excitation for eCFP and eYFP-containing 
channels (Ratio A). Ratio A-Ratio Ao is directly proportional to the 
FRET efficiency23. As shown in Figure 4d, Ratio A-Ratio Ao was   
significantly larger with CNGA1-∆CLZ than with CNGA1, when 
the  CNGA1  subunit  was  coexpressed  with  fluorescent  CNGB1. 
These results directly demonstrate that deletion of the CLZ domain 
caused multiple CNGB1 subunits to assemble.
A possible alternative explanation for the FRET seen between 
CNGB1 subunits with deletion of the CNGA1 CLZ domain is that 
the CNGB1 subunits are forming homomeric channels at low levels. 
Indeed, the fluorescence is considerably dimmer with co-expression 
of CNGA1-∆CLZ than with CNGA1. Previously, however, it has 
been shown that, in the absence of CNGA1, CNGB1 subunits do 
not form functional homomeric channels and are only very weakly 
expressed in the plasma membrane9,17. Similarly, we found that, in 
the absence of a CNGA1 subunit, both CNGB1 and CNGB1-∆N 
did not produce detectable currents and are poorly expressed in 
the plasma membrane (Supplementary Fig. S1). In addition, it was 
shown  previously  that  the  CNGB1  subunits  expressed  alone  do   
not  exhibit  appreciable  FRET9.  This  makes  it  unlikely  that  the 
increased FRET seen between CNGB1 subunits with deletion of   
the CNGA1 CLZ domain is from CNGB1 subunits forming homo-
meric channels.
Nevertheless, to prove that multiple CNGB1 subunits are co-
assembled with CNGA1-∆CLZ subunits, we examined the FRET 
between CNGA and CNGB subunits. For acceptor sensitization, the 
apparent FRET efficiency increases as the donor-to-acceptor ratio 
increases27. Therefore, if the donor fluorophore (eCFP) was fused to 
the CNGB subunit and the acceptor fluorophore (eYFP) was fused 
to the CNGA subunit, then an increase in apparent FRET should 
be seen if multiple CNGB1 subunits assembled in the channel com-
plex (Supplementary Fig. S2). Indeed, the results show a significant 
increase in FRET between eCFP-CNGB1-∆N and eYFP-CNGA1-
∆CLZ compared with eYFP-CNGA1 (Fig. 4e). These results indicate 
that multiple CNGB1 subunits are co-assembling with CNGA1-
∆CLZ subunits. Overall, it is clear that deletion of the CLZ domain 
relaxes the 3:1 constraint on subunit assembly.
The  CLZ  domains  of  CNGA1  and  CNGA3  form  trimers  in   
solution. The above results suggest that the CLZ domain has an 
important role in constraining the stoichiometry of rod CNG channels 
to 3:1 CNGA1:CNGB1 subunits. Previously, it has been shown that 
a protein fragment containing the CLZ domain from cone CNGA3 
forms homotypic trimers in solution8. To determine whether the 
CLZ domain from CNGA1 would also form trimers, and to localize 
the region involved, we screened a number of carboxy-terminal frag-
ments of both CNGA1 and CNGA3 using fluorescence-detection   
size-exclusion chromatography (FSEC) (Supplementary Fig. S3)28. 
The  protein  fragments  were  expressed  in  bacteria  as  N-terminal 
(NGFP) or C-terminal (CGFP) fusions to GFP. After cell lysis, the 
crude supernatant was then loaded on a size-exclusion chromato-
graphy system with an inline fluorescence detector. All the express-
ing fragments that contained the CLZ domain showed an appreciable 
component that eluted at 13 mL, consistent with the formation of 
a trimer (Fig. 5a). To verify the composition of the high molecular 
weight component, samples of the purified protein, following cleav-
age of GFP, were analysed by light scattering size-exclusion chroma-
tography (LS-SEC) (Fig. 5b)29,30. For both CNGA1 and CNGA3, the 
molecular weights determined from LS-SEC were within about 1% 
of the predicted molecular weights for a trimer (Table 1). Similar 
results with smaller fragments revealed a minimal fragment, corres-
ponding to the CLZ domain, that formed trimers in both CNGA1 
(amino acids 621–667) and CNGA3 (626–672) subunits.
X-ray crystallography reveals a three helix coiled-coil domain. 
The sequence of the CLZ domain exhibits periodic heptad repeats 
(a-b-c-d-e-f-g)n in which the ‘a’ and ‘d’ positions are hydrophobic   
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residues  (Fig.  1b)8.  This  motif  is  characteristic  of  coiled-coil 
domains31,32. There are two noncontiguous heptad repeat regions in 
each sequence; the first has three repeats and the second has two 
repeats. The two regions are out of register, with the ‘a’ position of   
the  first  region  becoming  the  ‘d’  position  of  the  second  region. 
While the presence of heptad repeats is fairly indicative of coiled-
coil domains, it is difficult to determine from the sequence alone 
the oligomeric state, parallel versus antiparallel arrangement, and 
details of the coiled-coil packing and surface architecture32. These 
properties have direct bearing on the mechanism of assembly, the 
interpretation of mutations, and the interaction with other proteins 
or domains. For these reasons, we were interested in obtaining the 
high-resolution structure of the CLZ domains.
We have solved the high-resolution X-ray crystal structures of 
the CLZ domains of both CNGA1 and CNGA3. The proteins were 
expressed and purified from bacterial cell lysates and crystallized 
under vapour diffusion. Crystals of CNGA1#621–690 grew in space 
group P212121 with three molecules in the asymmetric unit and   
diffracted to 2.14 Å. The structure of CNGA1#621–690 was solved 
using  molecular  replacement  with  the  structure  of  HIV  gp41   
N-trimer pocket region33 (3L36) as a search probe (Supplementary 
Table S1). The structure of CNGA3#626–672 in space group P1211 
was solved to 1.9 Å using molecular replacement with the structure 
of SARS virus S2 protein34 (1ZVB) as a search probe (Supplemen-
tary Table S1).
The structures of both CNGA1#621–690 and CNGA3#626–672 
consisted  of  long  (65 Å)  parallel  three-helix  coiled-coil  domains   
(Fig. 6). The sequence beyond the CLZ domain in CNGA1 (amino 
acids  665–675  for  chain  A;  665–676  for  chain  B;  and  665–670 
for chain C) flared outward and was partially involved in crystal 
packing  interactions  (Supplementary  Fig.  S4).  In  addition,  the 
CNGA1#621–690  structure  contained  two  bound  heavy  atoms 
per trimer with an electron density greater than 10 sigma (Fig. 6;   
Supplementary Fig. S5). These heavy atoms were coordinated by 
acidic residues (E629 and D633 for the proximal site, and E671 and 
E623 for the distal ion) at the interface between different trimers 
in the crystal and, therefore, are presumed to be non-physiological 
(Supplementary Fig. S5). They are likely to be Zn2 +  ions because of 
their coordination and the requirement for Zn2 +  in the crystalliza-
tion solution to produce crystals.
The  packing  of  the  coiled-coil  domains  followed  the  charac-
teristic ‘knobs into holes’ arrangement with the ‘a’ and ‘d’ positions 
forming alternating layers of the hydrophobic core of the coiled coil   
(Fig. 7)32,35. The two noncontiguous heptad repeat regions assem-
bled into a single continuous coiled coil. Interestingly, the CNGA1 
and CNGA3 structures differed in the length of the two heptad 
repeat regions. For CNGA1, the first region contained 3 heptad 
repeats and the second contained 3.5 repeats (Fig. 7b). For CNGA3 
the first region contained 4 heptad repeats and the second contained 
2.5 repeats (Fig. 7c). The difference appears to be the substitution   
of  an  isoleucine  for  a  leucine  after  the  third  heptad  repeat  in   
CNGA1 (Fig. 1b).
Although the structures of CNGA1 and CNGA3 were generally 
similar, they were not identical. As stated above, different residue 
positions were used in the helical packing between the two heptad 
repeat regions in the sequence. In addition, the supercoiling was   
different between CNGA1 and CNGA3, with a somewhat longer 
pitch for CNGA1 (181 Å) than for CNGA3 (149 Å) (Supplementary 
Table S2). These differences were also reflected in the structural 
alignments  of  the  individual  subunits  of  CNGA1  and  CNGA3   
(rmsd of Cα ranging from 0.87 Å to 2.0 Å). These differences in   
structure, however, do not have any known functional consequences.
Discussion
The results from the above experiments, and those of others, suggest 
a molecular mechanism for the controlled assembly of rod CNG 
channels  with  a  3:1  stoichiometry  of  CNGA1:CNGB1  subunits   
(Fig.  8a)6–9,20.  In  this  mechanism,  the  CNGA1  subunits  initially 
assemble  into  trimers  through  homotypic  association  of  their   
carboxy-terminal CLZ domains into a parallel three helix coiled coil. 
Subsequently, a CNGB1 subunit, if present, is preferentially incor-
porated into the remaining slot of the channel tetramer because of 
a high affinity association with CNGA1 subunits. This mechanism 
incorporates aspects of two previous models for heteromeric assem-
bly  of  CNG  channels:  initial  assembly  of  CNGA1  trimers8,  and 
high affinity association between CNGA1 and CNGB1 subunits9,21. 
The trimerization of the CLZ domain imposes the constraint that 
the channels contain at least three CNGA1 subunits, whereas the 
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Figure 6 | Structure of the trimeric coiled-coil CNGA CLZ complexes. 
Ribbon representation of the trimeric coiled-coil structures of CnGA1#621–
690 (a) and CnGA3#626–672 (b). Each complex is shown from a side 
(left) and top (right) perspective (top, n-terminus; bottom, C-terminus). 
The metal ions coordinated by the glutamate and aspartate residues at two 
sites in CnGA1#621–690 are shown as yellow spheres.
Table 1 | Summary of LS-SEC results.
CNGA1#621–690 CNGA3#626–694
Elution peak volume 14.8 ml 15.0 ml
mW (AsTRA method) 24.9 ± 0.7 kDa 23.8 ± 0.7 kDa
mW for monomer 
(predicted)
8.38 kDa 8.04 kDa
oligomeric state Trimer TrimerARTICLE     
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high affinity association between CNGA1 and CNGB1 assures that 
the fourth subunit is CNGB1. In support of this mechanism, we 
showed with electrophysiology and fluorescence that deletion of   
the CLZ domain in CNGA1 causes multiple CNGB1 subunits to 
incorporate into the heteromeric CNG channel. Furthermore, with 
X-ray crystallography we showed that there is a trimerization of   
the CLZ domain for both CNGA1 and CNGA3 (Fig. 5) that results 
from the formation of a parallel three helix coiled coil (Fig. 6).
In an elegant series of experiments, Yau and co-workers have 
proposed a mechanism for 3:1 CNGA:CNGB assembly that involves 
initial  assembly  of  CNGA  trimers8.  They  show  that  other  three   
helix coiled coils, but not two helix or four helix coiled coils, could 
substitute for the CLZ domain of CNGA channels to reproduce 
normal heteromeric channel function and expression20. However, 
whereas  we  found  that  deletion  of  the  CLZ  domain  causes  an 
increase in CNGB1 incorporation in the channels, they showed 
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that  mutations  in  the  CLZ  domain  decreased  the  incorporation 
of CNGB1 subunits20. Their results were explained by an assembly 
model where excess CNGA1 monomers outcompete CNGB1 mon-
omers for channel incorporation.
Instead, we propose that CNGB1 monomers outcompete CNGA1 
monomers  for  channel  incorporation  owing  to  a  high  affinity   
association of CNGA1 and CNGB1 subunits. A high affinity asso-
ciation between CNGA and CNGB subunits has been previously 
proposed to explain the dependence of the CNGA:CNGB ratio in   
the surface membrane as a function of the ratio of their RNAs 
injected into the oocyte9. A high affinity association of CNGA1 and 
CNGB1 subunits also explains the large dominant negative effect of 
CNGB1 on deletion of the CLZ domain in CNGA1 (Fig. 2a)21. When 
the  CLZ  domain  is  deleted,  the  CNGA1  subunits  preferentially 
interact with CNGB1 subunits, resulting in channels with multiple   
CNGB1 subunits that are not as efficiently expressed in the plasma 
membrane (Fig. 8b). This defect has been proposed to underlie   
one  form  of  inherited  retinitis  pigmentosa  resulting  from   
deletion  of  the  last  two  heptad  repeats  of  the  CLZ  domain  of   
CNGA1 (refs 21,22).
Previously,  it  has  been  shown  that  deletion  of  the  amino- 
terminal  region  of  CNGB1  could  partially  restore  expression  of   
these  CNGA1-∆CLZ-containing  channels21,  suggesting  that  the 
amino-terminal region of CNGB1 might be involved in the high-
affinity association between CNGA1 and CNGB1 subunits. Alter-
natively,  the  amino-terminal  region  of  CNGB1  could  contain  a 
trafficking  signal  for  incorrectly  assembled  heteromeric  CNG   
channels21. This trafficking signal could provide a mechanism for 
error-correction where channels with more than one CNGB1 sub-
unit are either poorly trafficked to the plasma membrane or rapidly 
removed from the membrane.
Beyond channel assembly, the CLZ coiled-coil domain may also 
serve as a scaffold for interactions with other proteins. Previously, 
it has been shown that the calmodulin binding site in the amino-
terminal region of CNGB1 directly interacts with the CLZ domain 
of  CNGA1  (refs  36,37).  Furthermore,  Ca2 + -calmodulin  disrupts   
this  interaction  resulting  in  separation  of  the  amino-terminal   
region of CNGB1 from the carboxy-terminal region of CNGA1   
(ref. 38). Also, the CLZ coiled-coil domain may be an important site 
of interaction for protein complexes that regulate channel activity, 
as has been proposed for Kv7 channels39–41.
Although the subunit stoichiometry of the rod CNG channel   
has  been  well  established,  the  stoichiometry  of  the  cone  CNG 
channel is still uncertain. Whereas some studies have suggested it 
also has a 3:1 stoichiometry of CNGA3:CNGB3, others have sug-
gested a 2:2 stoichiometry8,10. Here we find that the CLZ domain of 
CNGA3 forms a parallel three helix coiled coil that is similar to that 
of CNGA1. This suggests that the stoichiometry and mechanism   
of assembly for the cone CNG channel will be similar to that of the 
rod CNG channel. In addition, it has been shown that other three 
helix coiled-coil domains can substitute for the CLZ domain in cone 
CNG channels, but two and four helix coiled-coil domains cannot20. 
Interestingly, the olfactory CNG channel has a stoichiometry of 
2:1:1 CNGA2:CNGA4:CNGB1b9. Both the CNGA2 and CNGA4 
subunits have a CLZ domain (Fig. 1b). It remains to be determined 
whether the 2:1:1 stoichiometry comes about from a heterotypic 
three  helix  coiled  coil  of  the  CNGA2  and  CNGA4  subunits,  or 
from other intersubunit interactions such as seen at the level of the 
C-linker regions in the related hyperpolarization-activated cyclic 
nucleotide-gated channels19. In addition, the 3:1 stoichiometry of 
the TRPP2/PKD1 complex has recently been proposed to involve 
a trimeric coiled-coil domain in the carboxy-terminal region of 
TRPP2 (ref. 42), suggesting that the assembly mechanism of CNG 
channels may extend to other distantly related proteins.
Methods
Molecular biology. The bovine CNGA1 complementary DNA used was described 
previously43,44 and contains a C-terminal FLAG epitope (DYKDDYK). The bovine 
CNGB1 cDNA was a kind gift from Dr. R. Molday14 and the human CNGA3 
cDNA was a kind gift from Dr. K.W. Yau45. CNGA1-∆CLZ (CNGA1-∆609–693) 
and the CNGB1-∆N (CNGB1-∆2-765) were made as described21. CNGB1-∆N 
had a further manipulation, where its internal NcoI restriction site was removed 
via silent mutation and re-inserted at the initial methionine codon using a PCR-
based method. Improved monomeric versions of eCFP and eYFP (mCerulean and 
mCitrine) were employed in the generation of all fluorescent protein fusions with 
CNG subunits used for FRET experiments. cDNAs for mCerulean and mCitrine 
were kindly provided by Dr D Piston46 and Dr RY Tsien47, respectively. All con-
structs were confirmed with fluorescence-based automated sequencing. cDNAs were 
subcloned into the high-expression pGEMHE vector48 for expression in Xenopus 
oocytes. Vectors were linearized and complementary RNA (cRNA) was transcribed 
using the mMessage mMachine kit (Ambion). For co-injection experiments, rela-
tive amounts of RNA were quantified on agarose gels with a densitometric method. 
CNGA1 and CNGB1 were injected at an RNA ratio of 1:4 that has previously been 
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Figure 8 | Mechanism for the controlled assembly of heteromeric rod 
CNG channels. (a) The CnGA1 subunits (red) initially assemble into 
trimers through homotypic association of their carboxy-terminal CLZ 
domains into a parallel three helix coiled coil. subsequently, a CnGB1 
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shown to produce a pure population of heteromeric channels15. CNGA1-∆CLZ  
and CNGB1-∆N were injected at an RNA ratio of 1:2, and eCFP- CNGB1-∆N  
and eYFP-CNGB1-∆N were injected at an RNA ratio of 2:1.
Electrophysiology. Xenopus oocytes were microinjected with cRNA as previously 
described49. Cells were incubated at 16 °C for 5–8 days post-injection. Oocytes 
were patch clamped using the excised, inside–out configuration50 with an Axopatch 
200A patch-clamp amplifier (Axon Instruments) coupled to an ITC-16 AD con-
verter (Instrutech). Data were recorded and analysed with Pulse (Instrutech) and 
further analysed offline with Igor (Wavemetrics). Currents were filtered at 2 kHz 
and sampled at 10 kHz. Recordings were made at room temperature (~20 °C) using 
0.25–0.75 MΩ glass pipettes. Following excision, patches were placed in saturating 
cGMP solution for a minimum of 25 min to ensure complete run-up51.
Currents were recorded with voltage steps to  + 60 and  − 60 mV from a hold-
ing potential of 0 mV in the presence of saturating cGMP (2.5 mM) or saturating 
cAMP (16 mM). Leak currents recorded in the absence of cyclic nucleotide were 
subtracted. Bath and pipette solutions were identical and contained 130 mM NaCl, 
0.2 mM EDTA, and 3 mM HEPES, pH 7.2. Ligand-containing solutions were iden-
tical to the bath solution but contained saturating cGMP or cAMP (2.5 mM and 
16 mM, respectively). Internal solutions were applied with an RSC-100 solution 
changer (Molecular Kinetics).
A 10 mM L-cis-diltiazem (BIOMOL) stock solution was made in 2.5 mM  
cGMP recording solution, then aliquotted and frozen at  − 20 °C. L-cis-diltiazem 
dilutions in saturating cGMP recording solution were prepared immediately before 
the collection of dose-response data. Dose-responses of L-cis-diltiazem block were 
constructed from the unblocked, leak-subtracted current at the end of a  + 60 mV 
pulse as a fraction of the current elicited in saturating cGMP, with no L-cis-
diltiazem present. Dose-response relations were fit with either a single Langmuir 
isotherm: 
I I K K cis / /( [ - ]) max / / = + 1 2 1 2 L -diltiazem
or the sum of two Langmuir isotherms: 
I I X K K cis
X K K
/ /( [ - - ])
( ) /(
/ /
/ /
max
a a
b b
L diltiazem
 
= +
+ −
1 2 1 2
1 2 1 2 1 + +[ - ]) L -diltiazem cis
where K1/2 is the apparent affinity and X is the fraction of the high affinity compo-
nent (Ka
1/2) relative to the low affinity component (Kb
1/2).
Spectral FRET method. For FRET experiments, fluorescence images were  
collected using a X20 objective from the animal pole of oocytes with a confocal 
microscope (Leica SP1) using laser excitation at 458 nm and 488 nm. Regions of 
interest were drawn by hand in MetaMorph (Molecular Devices), and background 
fluorescence was quantified from the blank area inside the cell and subtracted 
(Supplementary Fig. S6). The pinhole was adjusted so that the brightest cells were 
within the linear range of the detector with a maximum pinhole setting of 1 Airy 
unit. Data from cells with very dim fluorescent signals were discarded. Emission 
spectra were constructed over a range of wavelengths with an emission window of 
2 nm. Spectra closely resembled the published spectra46,47, suggesting that the fluo-
rescent properties of these fluorescent protein variants are retained despite their 
incorporation into fusion proteins. FRET calculations were made using the spectral 
FRET method, as previously described7,9,23.
Protein biochemistry. Four different CLZ containing constructs of varying  
lengths were generated for both CNGA1 and CNGA3 (Supplementary Fig. 3).  
Each of these eight constructs was subcloned into two bacterial expression vectors,  
pNGFP_BC and pCGFP_BC (kindly provided by Dr. E. Gouaux), creating amino-
terminal and carboxy-terminal GFP fusion proteins respectively. Each of these 16 
constructs was screened by FSEC as previously described28. Briefly, 5 ml bacterial 
cultures were induced, spun down, and resuspended in 800 µl of 150 mM KCl, 
30 mM HEPES, pH 7.5 containing 2.5 µg ml − 1 DNAse and cOmplete protease 
inhibitor tablets (Roche). The cells were lysed with a probe sonicator; the lysate 
was cleared by centrifugation (1,700 × g for 30 min); and 100 µl of the supernatant 
was loaded on a Superdex 200 10/300 GL column (GE Healthcare) mounted on an 
FPLC system with a fluorescence detector set for detection of GFP fluorescence. 
Four candidates from the FSEC screen (CNGA1#621–690, CNGA1#621–667, 
CNGA3#626–694, and CNGA3#626–672) were subjected to further analysis.
For large scale protein preparations, the CNGA1 and CNGA3 channel frag-
ments were subcloned into the pETGQ and pETM11 vectors, respectively, creating 
amino-terminal poly-His fusion proteins. For the CNGA3#626–672 construct, 
the NcoI site at the amino terminus was deleted using PCR-based methods. Two 
litre bacterial cultures were grown to mid-log phase and induced with 1 mM IPTG 
overnight at 18 °C. The cultures were spun down and resuspended in 150 mM KCl, 
30 mM HEPES, pH 7.5 containing 1 mM AEBSF, 2.5 µg ml − 1 DNAse and cOmplete 
protease inhibitor tablets (Roche). Cells were lysed with an EmulsiFlex C-5 homo-
genizer (Avestin), and the lysate was cleared by centrifugation at 131,000 × g for 
45 min at 4 °C. The proteins were then purified on a Ni2 +  affinity resin column  
(HisTrap HP, GE Healthcare). The octahistidine tag was removed by thrombin  
(1) (1)
(2) (2)
or TEV cleavage, and the proteins were further purified on an anion or  
cation exchange column (HiTrap Q HP or HiTrap SP FF, GE Healthcare) and 
concentrated.
Two of the samples mentioned above (CNGA1#621–690, CNGA3#626–694) 
were submitted to the Biophysics Resource of the W.M. Keck Biotechnology  
Facility at Yale University (New Haven, CT) for LS-SEC analysis. The samples 
were run on a Superdex 200 10/300 GL column (GE Healthcare) in 150 mM NaCl, 
20 µM EDTA, 50 mM Tris–HCL, pH 8.0 (CNGA1#621–690) or 150 mM KCl, 
30 mM HEPES, pH 7.5 (CNGA3#626–694). The molecular weight was determined 
by solving the equation that relates the excess scattered light, measured at several 
angles, to the concentration of solute and the weight-average molar mass using  
the ASTRA program30.
X-ray crystallography. Crystals were grown by the sitting drop, vapour diffusion 
method at 20°C. Crystals of CNGA1#621–690 grew using a 1:1 mixture of protein 
and reservoir solution containing 18.2% (w/v) PEG 3350, 45 mM Zn2 +  acetate, 
9 mM CoCl2. These conditions produced crystals within 8 days with space group 
P212121 that diffracted to a resolution of 2.14 Å. Crystals of CNGA3#626–672 grew 
using a 1:1 mixture of protein and reservoir solution containing 20% (w/v) PEG 
3350, 200 mM K +  acetate. These conditions produced crystals within 1 day with 
space group P1211 that diffracted to a resolution of 1.9 Å.
For diffraction data collection, crystals were immersed in liquid nitrogen  
after cryoprotection in 20% glycerol. Data were collected at 110 °K on beamline 
8.2.1 at the Advanced Light Source (Lawrence Berkeley National Laboratory,  
Berkeley). Integration, scaling and merging of the diffraction data were done 
with the Mosflm program52. The structures were solved by molecular replacement 
using the programs Phaser53 and Phenix54. For CNGA1, the structure of HIV gp41 
N-trimer pocket region33 (3L36) was used as a search probe. For CNGA3, the 
structure of SARS virus S2 protein34 (1ZVB) was used as a search probe. Molecular 
models were rebuilt using ARP/wARP (ref. 55) (CNGA1) or the Phenix software 
suite54 (CNGA3). Structure refinement and validation were performed using the 
Phenix software suite54 and the program Coot56 using Fo – Fc ′omit′ maps. Based 
on the Ramachandran plot, the percent of amino acids in favoured/allowed/
disallowed conformations were 99.37/0.63/0.0 for CNGA1 and 100.00/0.0/0.0 for 
CNGA3. The coiled-coil parameters were analysed by the program TWISTER57.
Statistical analysis. Data parameters were plotted as mean ± s.e.m. Student’s test 
was used to determine significance at P < 0.05. 
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